Search

Chinese
Resource Library / Biomarker and Alzheimer’s disease: role of high sensitivity assays and the applications

webinar

Biomarker and Alzheimer’s disease: role of high sensitivity assays and the applications

It has been said that the diagnosis of Alzheimer's disease enters the era of biomarkers. These two biomarkers, amyloids, and taus, defines Alzheimer's disease. In this presentation, Dr. Kai Wang, Senior Director of Biomarker Services at Frontage Laboratories, Inc, focuses on highly sensitive protein biomarker assays developed and validated at a testing laboratory and their application for the diagnosis of Alzheimer's disease.

Resource Preview

Resources to Consider

Left arrow
Validation of a 384 gene hybridization capture-based pharmacogenomics NGS panel: sensitivity, specificity, accuracy, and reproducibility in calling star alleles for drug metabolism genes
poster

Validation of a 384 gene hybridization capture-based pharmacogenomics...
​Frontage has developed a next-generation sequencing (NGS)-based method to rapidly deter...
Access Resource
Neurofilament Light Chain: Method Validation of Quantitation Using the Quanterix Simoa™ Platform and Potential Applications
poster

Neurofilament Light Chain: Method Validation of Quantitation Using...
In this study, we quantify Neurofilament Light Chain (NF-L) in human plasma, serum, and CS...
Access Resource
Human Gut Microbiome-Based Contract Research Applications in Toxicology and Microbiome-Based Drug Discovery
webinar

Human Gut Microbiome-Based Contract Research Applications in...
The human gut microbiome contains a complex aggregate of colonic bacterial enzymes mediati...
Access Resource
Right arrow